IL33 and neoplasm: Altogether, these studies suggest functional divergence of IL-33 when acting on tumour cells and the immune infiltrate, where direct action of IL-33 on tumour cells induces desmoplasia and tumour invasion, while IL-33-mediated stimulation of tumour infiltrating lymphocytes may conversely limit CRC metastasis.